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Toggenburg Orbivirus, a new bluetongue virus: Initial detection,
first observations in field and experimental infection of goats and
sheep
Abstract
A novel bluetongue virus termed "Toggenburg Orbivirus" (TOV) was detected in two Swiss goat flocks.
This orbivirus was characterized by sequencing of 7 of its 10 viral genome segments. The sequencing
data revealed that this virus is likely to represent a new serotype of bluetongue virus [Hofmann, M.A.,
Renzullo, S., Mader, M., Chaignat, V., Worwa, G., Thuer, B., 2008b. Genetic characterization of
Toggenburg Orbivirus (TOV) as a tentative 25th serotype of bluetongue virus, detected in goats from
Switzerland. Emerg. Infect. Dis. 14, 1855-1861]. In the field, no clinical signs were observed in
TOV-infected adult goats; however, several stillborn and weak born kids were reported. Although born
during a period of extremely low vector activity, one of these kids was found to be antibody and viral
genome positive and died 3.5 weeks postpartum. Experimental infection of goats and sheep, using
TOV-positive field blood samples, was performed to assess the pathogenicity of this virus. Goats did not
show any clinical or pathological signs, whereas in sheep mild bluetongue-like clinical signs were
observed. Necropsy of sheep demonstrated bluetongue-typical hemorrhages in the wall of the
pulmonary artery. Viral RNA was detected in organs, e.g. spleen, palatine tonsils, lung and several
lymph nodes of three experimentally infected animals. Unlike other bluetongue virus serotypes, it was
not possible to propagate the virus, either from naturally or experimentally infected animals in any of
the tested mammalian or insect cell lines or in embryonated chicken eggs. In small ruminants, TOV
leads to mild bluetongue-like symptoms. Further investigations about prevalence of this virus are needed
to increase the knowledge on its epidemiology.
 1
Toggenburg Orbivirus, a new bluetongue virus: Initial detection, first 
observations in field and experimental infection of goats and sheep 
 
Valérie Chaignat a, Gabriella Worwa a, Nicole Scherrer a, Monika Hilbe b, Felix 
Ehrensperger b, Carrie Batten c, Mandy Cortyen c, Martin Hofmann a, Barbara Thuer a* 
 
a
 Institute of Virology and Immunoprophylaxis, Sensemattstrasse 293, 3145 
Mittelhaeusern, Switzerland 
b Institute for Veterinary Pathology, Vetsuisse Faculty, Winterthurstrasse 268, 8057 
Zuerich, Switzerland 
c
 Institute for Animal Health, Ash Road, Pirbright, Woking, GU24 ONF, United Kingdom 
 
* Corresponding author: 
Barbara Thuer 
Phone +41 31 848 92 51 
Fax +41 31 848 92 22 
E-mail: barbara.thuer@ivi.admin.ch 
 2
Abstract 
 
A novel bluetongue virus termed "Toggenburg Orbivirus" (TOV) was detected in 2 
Swiss goat flocks. This orbivirus was characterized by sequencing of 7 of its 10 viral 
genome segments. The sequencing data revealed that this virus is likely to represent a new 
serotype of bluetongue virus (Hofmann et al., 2008b). 
In the field, no clinical signs were observed in TOV-infected adult goats; however, 
several stillborn and weak born kids were reported. Although born during a period of 
extremely low vector activity, one of these kids was found to be antibody and viral genome 
positive and died 3.5 weeks post partum. 
Experimental infection of goats and sheep, using TOV-positive field blood samples, 
was performed to assess the pathogenicity of this virus. 
Goats did not show any clinical or pathological signs, whereas in sheep mild 
bluetongue-like clinical signs were observed. Necropsy of sheep demonstrated bluetongue-
typical hemorrhages in the wall of the pulmonary artery. Viral RNA was detected in organs, 
e.g. spleen, palatine tonsils, lung and several lymph nodes of 3 experimentally infected 
animals. 
Unlike other bluetongue virus serotypes, it was not possible to propagate the virus, 
either from naturally or experimentally infected animals in any of the tested mammalian or 
insect cell lines or in embryonated chicken eggs. 
In small ruminants, TOV leads to mild bluetongue-like symptoms. Further 
investigations about prevalence of this virus are needed to increase the knowledge on its 
epidemiology. 
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1. Introduction 
 
Bluetongue (BT) is a non-contagious, vector-borne disease of ruminants, which is 
almost exclusively transmitted by arthropods of the species Culicoides. Bluetongue virus 
(BTV), an orbivirus belonging to the family Reoviridae, is a double-stranded RNA virus 
comprising 24 serotypes. Although BTV can clinically infect certain breed of sheep and 
some species of deer, clinical disease is rarely seen in goats and cattle and infection is 
mostly unapparent in most wild ruminants species (MacLachlan, 2004; Lefevre et al., 2008; 
Backx et al., 2007). However, in the recent outbreak caused by bluetongue serotype 8 
(BTV-8) in Europe, cattle were clinically severely affected (Guyot et al., 2007). 
Until 2006, BTV infection was recognized as an enzootic disease in areas between 
latitudes 35 °S and 40 °N (Saegerman et al., 2007). Prior to 1998, occasional short-lived 
incursions of BTV occurred in southern Europe (Spain, Portugal, Greece and Cyprus). 
However, since 1998, at least 9 distinct virus strains from 6 different serotypes (namely 
serotypes 1, 2, 4, 6, 8, 9 and 16) have invaded Europe, including many northern European 
countries for BTV-8 (Saegerman et al., 2008; Anonymous, 2008c). Serotype 8 was detected 
for the first time in August 2006 in Northern Europe, in Belgium and the Netherlands 
(Elbers et al., 2008). The disease spread rapidly through Northwestern Europe (Wilson et 
al., 2007); therefore surveillance and movement control were intensified within the 
European Community as well as in Switzerland. The first case of BTV-8 was detected in 
Switzerland in clinically affected cattle in October 2007 (Hofmann et al., 2008a). The 
introduction of BTV-8 to Northern Europe has resulted in BTV spreading to 53 °N 
(Anonymous, 2006a). 
In November and December 2007, prior to any vaccination campaign against BTV-8 
in Europe, blood samples from 2 flocks of healthy goats were examined for the presence of 
BTV antibodies (Ab) and BTV RNA by ELISA and real time RT-PCR (rRT-PCR) at the 
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Institute of Virology and Immunoprophylaxis (IVI), prior to movement outside the 
surveillance or protection zone. In both flocks, ELISA and rRT-PCR (based on BTV 
genome segment 10) yielded positive results; however, concordance between serological 
and rRT-PCR results was not observed in all animals. To clarify these laboratory results, 2 
confirmatory rRT-PCRs targeting BTV genome segment 5 were performed. The "rRT-PCR-
FLI", optimized for BTV-8 detection (M. Beer and B. Hoffmann, Friedrich Loeffler 
Institute [FLI], Island of Riems, Germany, personal communication) and the "rRT-PCR-
Toussaint", able to detect BTV reference strains representing all 24 serotypes (Toussaint et 
al., 2007) gave negative or weak positive reactions indicated by high Ct-values. Due to 
these inconclusive diagnostic results and the fact that, no epidemiological link between the 
field case B and other BT outbreaks was found, a closer investigation to genetically 
characterize the BTV strain circulating in these flocks was performed. Genome segments 2, 
5, 6, 7, 8, 9, and 10 of the virus present in the flock from the Toggenburg region, which was 
termed "Toggenburg Orbivirus" (TOV), were sequenced (Hofmann et al., 2008b). The 
sequences were submitted to GenBank under accession numbers EU839840 (segment 2), 
EU839841 (segment 5), EU839842 (segment 6), EU839843 (segment 7), EU839844 
(segment 8), EU839545 (segment 9) and EU839846 (segment 10). BLAST analysis of these 
genome segments indicated in all cases a high sequence similarity to BTV. Since only 63% 
sequence identity to any of the 24 BTV reference strains was found for segment 2, TOV is 
likely to represent a so far unknown 25th serotype of BTV. As it was unknown if TOV is 
able to induce any clinical disease in goats and sheep, or if TOV is infectious for sheep at 
all, goats and sheep were experimentally infected with TOV-positive blood samples 
collected from the field. Attempts to isolate TOV in cell cultures and in embryonated 
chicken eggs (ECE) were also performed. 
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2. Material and methods 
 
Initial detection of TOV-infected animals 
Holding A: Solothurn region 
Two healthy Grisons striped goats from the northern part of Switzerland were tested 
for the presence of BTV genome and Ab prior to leaving the BT protection zone for trade 
purpose. The holding had been inside the BTV-8 protection zone for 1 month and the 
closest BTV-8 case was 7 km away. The farm consisted of 28 additional goats (mostly 
Grisons striped goats and a few cross breeds) and 7 Hinterwald cattle. The goats and cattle 
shared pastures. 
Holding B: Toggenburg region 
Before exportation to Sweden, 12 Peacock goats and 32 alpacas were tested for the 
presence of BTV genome and Ab. This holding was located in the northeastern part of 
Switzerland, a region where no BT cases had been identified previously. The closest 
bluetongue outbreak was in Germany, more than 100 km away. There was no 
epidemiological link to other BT cases. Goats were born in Switzerland and no alpacas 
were imported onto this farm during 2007. The goats and alpacas were kept on separate 
pasture, as often as possible. Additionally, 6 kids born to this herd in spring 2008, during a 
period of very low vector activity, were also tested for BTV prior to export. 
 
In both farms, the animals were not protected against midges. The holdings were 
located at approximately 700 m above sea level. 
Follow-up was performed on these holdings by telephone interview of owners and 
veterinarians to obtain information regarding clinical observations, environmental factors, 
husbandry and herd history. 
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Sample processing 
a) red blood cell washing procedure 
To remove BTV-neutralizing Ab and EDTA, blood was washed 3 times and the red 
cells fraction was resuspended in phosphate buffered saline (PBS), aliquoted and frozen at 
–70 °C. 
b) isolation of white blood cells 
Buffy coat was prepared using the method described by Mishell and Shiigi (1980). 
Cell pellets were resuspended in 1 mL PBS and stored for less than 24 h at 4 °C prior to 
RNA extraction. 
c) preparation of organs for virus detection 
A 10% (w/v) suspension of homogenized tissue was prepared in cell culture medium 
containing antibiotics (MEM with 25 mmol/L HEPES and penicillin/streptomycin; GIBCO, 
Invitrogen Corporation, Carlsbad CA 92008, USA) using an Ultra-Turrax T25 homogenizer 
(IKA, Stauffen, Germany), followed by centrifugation for 15 min at 20 800 x g. Clarified 
supernatant was frozen at –70 °C prior testing in rRT-PCR. 
 
Serology 
a) Ab detection by commercial ELISAs 
Plasma was used for the detection of BTV-specific Ab by ELISA. Screening was 
performed in duplicate wells with Bluetongue Virus Antibody Test Kit (VMRD, Pullman, 
WA, USA). For confirmation, 2 additional ELISAs, Blue Tongue Competitive ELISA Kit 
(B.D.S.L., Irvine, UK) and ID.Screen Blue Tongue Competition ELISA Kit (ID.VET, 
Montpellier, France) were used. 
Serum and plasma samples from experimentally infected animals were additionally 
tested with INGEZIM BTV DR1 (INGENASA, Madrid, Spain) and Pourquier ELISA 
Bluetongue Serum (Institut Pourquier, Montpellier, France). The tests were used according 
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to the manufacturers instructions. All ELISAs are designed to specifically detect Ab against 
BTV VP7 (Anonymous, 2006b). 
Milk from experimentally infected goats was tested for the presence of Ab by an 
indirect ELISA (ID Screen Bluetongue Milk Indirect, ID.Vet) following the manufacturers 
instructions. 
b) serotyping by virus neutralization test 
To determine the BTV serotype by virus neutralization test (VNT), 4 strongly 
ELISA-positive sera from holding B were sent to the OIE reference laboratory for BT 
(Institute for Animal Health [IAH], Pirbright, UK). The VNT was performed according to 
the method of Haig et al. (1956), using South African BT reference viruses (SA BTV) and 
serotype-specific positive control antisera. 
Briefly, sera were titrated against each of the 24 BTV reference strains starting at a 
serum dilution of 1:10. Hundred µl of each of the SA BTV containing 100 CCID50 (50% 
cell culture infective dose) was added to the serum dilution. The 96-well plates were 
incubated for 1 h at 37 °C and then transferred to 4 °C overnight. The following day, 50 µL 
of a 2 × 105 /mL Vero cell (African green monkey kidney) suspension were added per well 
and after incubation for 4 to 7 days at 37 °C, the wells were scored for cytopathic effect 
(CPE). The neutralization titer was determined as the dilution of serum yielding a 50% 
neutralization end point. 
 
Nucleic acid and virus detection 
a) extraction of RNA and rRT-PCR 
Total RNA was extracted manually from EDTA blood by Trizol (Invitrogen) or in a 
semi-automated way using NucleoSpin Multi-96 Virus extraction kit (Macherey-Nagel, 
Düren, Germany) on a Genesis Freedom EVO robot (TECAN, Männedorf, Switzerland). 
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A recently published rRT-PCR protocol, targeting segment 10 (Hofmann et al., 
2008a), termed “rRT-PCR-CH”, was used to detect BTV. Viral RNA was heat-denatured in 
the presence of both primers (forward primer [5’-TGGAYAAAGCGATGTCAAA-3’], 
reverse primer [5’-ACATCATCACGAAACGCTTC-3’], probe [5’FAM-
ARGCTGCATTCGCATCGTACGC-3’BHQ1]), Microsynth, Balgach, Switzerland) at 95 
°C for 5 min, followed by rapid cooling on ice. SuperScript™ III One-Step RT-PCR System 
with Platinum Taq (Invitrogen) was used as reaction mix, and cycling was done with the 
thermal profile 48 °C (30 min) / 95 °C (2 min) / 50x [95 °C (15 s) / 56 °C (30 s) / 72 °C (30 
s)]. All samples were tested in triplicate wells. Samples with any Ct-values <50 were 
interpreted as positive. 
b) virus isolation 
Washed red blood cells and tissue homogenates were inoculated on different 
mammalian cell lines, namely BHK-21 (Baby Hamster Kidney, American Type Culture 
Collection [ATCC]), Vero (ATCC) and on ETH-R (bovine aorta endothelium, kindly 
provided by FLI). Additionally, several insect cell lines, such as Sf9 (Spodoptera 
frugiperda, ATCC), High5 (Spodoptera frugiperda, ATCC) and KC (larva of Culicoides 
variipennis) were tested. 
Mammalian cells were incubated at 37 °C with 5% CO2 and insect cells at 28 °C. 
Cells were observed daily for CPE for 5 to 7 days post inoculation (dpi). Cells were either 
freeze-thawed or scraped off with a sterile scraper and disrupted by ultrasound. The 
supernatant was centrifuged at 191 x g for 10 min and tested for the presence of BTV RNA 
by rRT-PCR-CH. Positive supernatants were repassaged onto the same cell line. In addition, 
supernatants from insect cell culture were passaged onto BHK-21 or Vero cells. 
In parallel, 100 µL of washed blood or cell culture supernatant were inoculated 
intravenously or into allantoic fluid of 10 to 12 day old SPF ECE according to the OIE 
Guidelines (Anonymous, 2008a). Allantoic fluid and organs of chicken embryos were 
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harvested separately and stored at 4 °C prior to RNA extraction and testing by rRT-PCR-
CH. 
 
Experimental infection of goats and sheep 
All animals were held according to the laws on care and use of laboratory animals in 
Switzerland. Experiments were approved by the state committee for animal experimentation 
and were performed in animal rooms in biosafety level 4 containment at IVI. Goats and 
sheep were housed separately. Before infection, all animals were checked to be free from 
BTV RNA by using rRT-PCR-CH and BTV Ab by VMRD ELISA. At the end of the 
experiment, the animals were humanely euthanized and necropsy was performed. 
Two 14 month old Saanen goats (goat #1 and 2) in lactation were inoculated twice 
intravenously (i.v.) with 40 mL washed red blood cells from holding B, as described in 
Table 1, and subsequently monitored for 18 days. The goats were milked twice a day to 
monitor milk production and presence of Ab against BTV and viral RNA in milk was 
examined. Seven White Alpine sheep (sheep #1-7) between 10 and 12 months of age were 
inoculated twice with washed red blood cells from the goats #1 and #2. Additionally, one 
sheep (sheep #8) was mock-inoculated with TOV-negative goat blood. The inoculation 
scheme is presented in Table 1. This inoculation method had been previously validated in 
experimental BTV-8 infection of sheep (Worwa et al., 2008). Sheep were clinically 
examined daily until the end of the trial at 64 dpi. Every day, EDTA blood was collected 
from goats until 18 dpi, and from sheep daily between 0 and 21 dpi, then twice a week until 
49 dpi, finally weekly until the end of the trial. The clinical evaluation was performed using 
a standardized form, developed at the IVI for experimental infection of Swiss breed sheep 
with BTV-8 (Worwa et al., 2008). This protocol was adapted from already published 
protocols (Hooper et al., 1996; Hamblin et al., 1998; Veronesi et al., 2005; Darpel et al., 
2007; Anonymous, 2008b). 
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At necropsy, blood and organs from goats were collected for further experiments. 
One part of these samples (lung, heart, pulmonary artery, aorta, lip, tongue, palatine tonsils, 
several lymph nodes, thyroid, spleen, liver, kidney, adrenal gland, pancreas, rumen and 
brain) were fixed in 4% formalin, embedded in paraffin and stained with hematoxylin-eosin 
for histological examination. The remainder of these samples was tested by rRT-PCR-CH. 
Depending on the macroscopical lesions, additional tissues were taken and examined. From 
sheep several tissue samples were collected (lung, palatine tonsils, lymph nodes, spleen, 
liver, brain, heart, testicle and kidney), tested for presence of BTV RNA and histologically 
examined.
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3. Results 
 
Field data 
Holding A 
The 2 healthy goats initially tested for trade purposes were positive in VMRD ELISA 
and rRT-PCR-CH (Table 2). However, the amplification curves showed ∆ Rn values much 
lower than usually observed with other positive BTV samples (data not shown). The 
confirmatory rRT-PCR-Toussaint yielded equally weak positive results. 
Due to the positive laboratory results follow-up, investigations of the herd were 
performed. A census revealed additional 28 goats and 7 cattle on the holding, which were 
held together on pasture. One goat died a few days earlier due to unknown reasons, and 2 
goats presented slightly swollen heads on day of sampling. The remaining ruminants were 
clinically healthy. Twenty, including the goats with swollen heads, of the 37 goats were 
serologically positive in the VMRD ELISA. Two additional goats were determined to be 
positive in rRT-PCR-CH. The goat, which died previously, was found to be negative for 
viral RNA postmortem. One month later, the animals were re-sampled and 2 more goats 
were found positive for RNA in the rRT-PCR-CH, as shown in Table 2. Sequencing data 
confirmed the presence of TOV in this holding. 
Follow-up of this farm revealed a few abortions, stillbirths and weak born animals in 
winter 2007 and spring 2008, most of them in the context of multiple births. As the 
frequency did not exceed the normal loss rate, no investigation was performed by the 
veterinarians. 
Holding B 
All goats and alpacas had always been clinically healthy. The blood samples from all 
tested goats yielded positive results in rRT-PCR-CH. However, they were negative in the 2 
confirmatory rRT-PCRs, e.g. rRT-PCR-FLI and rRT-PCR-Toussaint. At the time of the 
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first blood sampling, BTV Ab were present in only 4 animals. After re-sampling 1 and 3 
weeks later, 2 and 4 more animals respectively, had seroconverted as determined by the 
detection of BTV Ab by ELISAs (Table 3). None of the 4 strong ELISA-positive sera 
showed neutralizing activity with any of the 24 BT reference serotypes. The 32 alpacas 
were all negative for BTV Ab and RNA in the VMRD ELISA and in rRT-PCR-CH. 
In April 2008, shortly prior to exportation of the animals to Sweden, 6 kids, born in 
the meantime, were tested for BTV. No newborn alpacas were present on the holding at 
that time. Four of the kids had BT Ab and 1 was also positive for BTV RNA by rRT-PCR-
CH (Ct-value of 23.2 in EDTA blood). This kid, born on 18.02.08, was transferred to the 
animal facility at IVI for further investigations. It presented swallowing troubles, muscle 
weakness, central nervous system disorders and coordination problems and died a few days 
after arrival. Necropsy did not reveal any gross nor histopathological findings. However, 
most of the organs contained BTV RNA, detected by rRT-PCR-CH; spleen (Ct-value 32.6), 
testicle (Ct-value 39.4), lung (Ct-value 40), liver (Ct-value 38). In other organs, such as 
myocard, several lymph nodes, adrenal gland, thymus, pancreas and abomasum, vestiges of 
viral RNA were found (1 triplicate positive). 
Blood from adult animals on this holding was used for experimental infection of 
goats as described below. 
After export to Sweden, the Swedish veterinary authorities (Statens 
Veterinärmedicinska Anstalt, Enhet för Virology, Immunologi och Parasitologi, Uppsala, 
Sweden) found BTV Ab in all the adult goats and the exported kids using the ID.VET 
ELISA but did not obtain positive results by using rRT-PCR-FLI. Since Sweden was still 
free from BTV, the entire goat flock was slaughtered to avoid any spread of the virus. 
 
Experimental animal infection 
Goats 
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During the whole trial, the inoculated goats did not show any BT-specific clinical 
signs and body temperature remained in the normal range. Milk production was stable at 
quite a high level (about 4 L/day). No BTV Ab was detected in plasma until 17 dpi, 
thereafter goat #1 was tested positive in plasma. Body temperature and Ct-values for EDTA 
blood obtained with rRT-PCR-CH are shown in Figure 1A. The highest amount of viral 
RNA in organs was found in spleen, lower amounts in lung, lymph nodes and palatine 
tonsils (Table 4). In milk, no BTV Ab was detected and rRT-PCR-CH yielded negative 
results. 
At necropsy, the 2 goats showed moderately enlarged lymph nodes and the white 
pulp of the spleen was clearly visible. In goat #1, an abscess was present in the right 
prescapular lymph node. No BT-specific pathological alterations were observed in any 
tissues. 
Histologically, a moderate to strong reactive hyperplasia in the lymph node, spleen 
and Peyer’s patches was found in both goats. Goat #1 showed a suppurative lymphadenitis 
in the affected prescapular lymph node (most likely induced by bacteria). In the Tunica 
media of the pulmonary artery of goat #2, a small focal acute perivascular hemorrhage and 
few perivascular arranged lymphocytes were present. 
Sheep 
Sheep did not exhibit fever, defined as body temperature >40.5 °C, but slightly 
elevated temperature (38.5 to 40.3 °C) were occasionally recorded (Fig. 1B). Body 
condition remained very good throughout the trial. All inoculated animals presented 
sporadically red conjunctivas, hyperemic mucous membranes of the nose and slightly 
swollen lymph nodes, whereas the negative control animal showed none of these signs. 
Three (sheep #1, 2 and 3) of 7 infected animals had intermittently slightly warm hooves. 
Between 13 to 15 dpi, 2 infected ewes (sheep #2 and 6) showed a reddened and swollen 
vulva with some pustules. Discrete nose lesions such as erosions, vesicles and epithelial 
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abrasions, were sporadically seen in 6 sheep (#1-5 and 7) between day 6 and day 21 post 
infection (pi). Mouth mucosal erosions appeared in 1 animal (sheep #4) at days 19 and 
20 pi. Three sheep (#3, 5 and 7) presented a large and deep skin lesion on the sternum 
between days 9 and 28 pi. Sheep #5 had purulent vesicles on 1 foot at day 28 and 29 pi. 
Until 16 dpi, none of the sheep showed a detectable BTV Ab response. Thereafter, 
for sheep #7, the VMRD ELISA scored positive or showed results just below the cut-off 
up to the end of the animal experiment. At 31 and 35 dpi, VMRD ELISA results slightly 
below the cut-off were also seen in sheep #6. All the other animals remained clearly 
negative. B.D.S.L. ELISA confirmed these results. 
ID.VET and Pourquier ELISA did not detect any Ab in sera from the sacrificed 
sheep, whereas VMRD and INGENASA as well as B.D.S.L. ELISA confirmed the presence 
of BTV Ab in sheep #7. 
No viral RNA in blood of sheep #1, 2, 3 and 5 was detectable by rRT-PCR-CH at any 
time point. In sheep #7, low levels of BTV RNA were repeatedly detected between 9 and 27 
dpi, and in sheep #6 at 24 and 27 dpi, as well as in sheep #4 at 27 dpi (Fig. 1B). Sera, 
EDTA blood and buffy coat from sheep #7 were tested by rRT-PCR-CH. Lower Ct-values 
were obtained in EDTA blood than in sera and in buffy coat. In contrast to EDTA blood, 
sera and buffy coat were only positive for a short period at the beginning of the viraemia 
(data not shown). Furthermore, BTV RNA was detected in kidney and spleen of sheep #7 
(Table 4). In all other samples, including testicle and pericardial fluid, no BTV RNA was 
found. 
At necropsy, all sheep showed moderately activated lymph nodes and the white pulp 
of the spleen was clearly visible. In the wall of the pulmonary artery, multiple hemorrhages 
of different sizes (0.3 to 0.8 cm diameter) were observed in 4 sheep (#2, 3, 6 and 7) (Fig. 
2A). Additional hemorrhages were observed on the endocardium at the passage between 
right atrium and ventricle in 4 infected sheep (#1-3 and 7) (Fig. 2B). Furthermore, sheep #7 
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presented several petechial and ecchymotic hemorrhages on the surface of the epicardium 
(Fig. 2C) and sheep #6 had edematous atrio-ventricular valves. Twenty mL of clear fluid 
was found in pericardial sac of sheep #7. Sheep #6 showed small hemorrhages on the lips. 
No pathological alterations were found in the control animal. 
Histologically, a reactive hyperplasia of lymph nodes and spleen was observed in all 
the sheep. In sheep #2, 3, 6 and 7, the Tunica media of the pulmonary artery showed small 
multifocal acute perivascular hemorrhages. 
 
Virus isolation in cell culture and in ECE 
No virus replication was observed in any of the cell cultures inoculated, neither in 
ECE. After subsequent blind passages on the same cell lines, no virus growth was detected 
neither.
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4. Discussion 
 
TOV, a new orbivirus likely to represent a new 25th serotype of BTV, was detected in 
clinically healthy goats and was characterized by sequence analysis of genome segments 2, 
5, 6, 7, 8, 9 and 10 (Hofmann et al., 2008b). To study the clinical and pathological 
symptoms in small ruminants and to determine whether the virus can be transmitted via goat 
blood to sheep, in vivo experiments were performed. 
Two holdings (A and B) were found to contain goats positive for BTV Ab and viral 
RNA as part of routine pre-export testing. Holding B had no epidemiological link to other 
BTV cases and therefore it was considered a primary outbreak. The rRT-PCR-CH gave 
weak positive results and the shape of the amplification plot was uncharacteristic for the 
assay and further investigation was performed to confirm BTV infection. Although each 
BTV rRT-PCR used at IVI is serogroup-specific, they do not target the same BTV genome 
segment and therefore, rRT-PCR-CH (against genome segment 10) is used as preliminary 
test and rRT-PCR-Toussaint and rRT-PCR-FLI as confirmatory tests. The rRT-PCR-CH 
has been validated against all 24 BTV serotypes and based on the segment 10 sequence 
alignment of all 24 BTV serotypes (92 sequences available on GenBank) and no 
mismatches in primers and probe used in this assay were observed. The detection of RNA 
using the rRT-PCR-CH assay, and the absence of reaction in the confirmatory rRT-PCRs as 
well as the weak response in several ELISAs indicated that the animals in holding B were 
infected with a BTV-like virus, later to be regarded as TOV (the 25th BTV serotype) 
(Hofmann et al., 2008b). For Ab detection, the moderate positive results obtained in VMRD 
ELISA were clearly confirmed by using the more sensitive B.D.S.L. ELISA.  
Blood from the infected animals on holding B was used as inoculate for animal 
experiments. Similar to the observations on holdings A and B, no BT-specific clinical signs 
were observed in experimentally infected goats. In sheep only mild clinical signs were seen. 
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Goats did not show any BT-specific gross pathological lesions. In contrast, histological 
findings, e.g. perivascular hemorrhages in Tunica media of pulmonary artery, are 
considered as typical during bluetongue infection. The macroscopic hemorrhages in the wall 
of the pulmonary artery, in sheep, were considered as BT-specific (Erasmus, 1975). Most 
likely, virus replication took place in only 3 of the 7 inoculated sheep (sheep #7, 4 and 6). 
One reason could be that the Ct-value of the inoculate was much lower than in previous 
experiments with BTV-8 (Worwa et al., 2008). The inoculate used for experimental 
infection of the sheep, derived from the blood of goats #1 and #2, demonstrated a low viral 
load as demonstrated by high Ct-values. 
Although in the field adult goats did not show any BT-specific clinical signs, the 
finding that some kids were weak or still born should be investigated more thoroughly in 
relation to the possibility of transplacental infection. In cattle, it has been demonstrated that 
BTV-8 can cross the placenta and infect the fetus (Desmecht et al., 2008) and similar 
observations were made in sheep (Worwa et al., in press). The rRT-PCR positive kid, born 
during the officially declared vector-free period, survived only 3.5 weeks. It had a high viral 
RNA load, demonstrated by low Ct-values in rRT-PCR, but showed also a strong Ab 
reaction in ELISA. Two goats experimentally infected with its blood did not show any 
viraemia nor seroconversion (data not shown). Therefore, it seems that this animal was not 
infectious anymore when used for direct animal infection at the time of blood sampling. In 
cattle and sheep with high levels of BTV-8 colostral Ab and high viral load (low Ct-value), 
it has not been possible to isolate virus by conventional methods (Karin Darpel, personal 
communication), this may explain why the blood of the kid was not infectious for the 
experimentally inoculated 2 naïve goats. However, De Clercq et al. (2008) isolated virus 
from 2 out of 123 newborn transplacentally infected calves that had not ingested colostrum. 
Moreover, it can not be excluded that the blood from BTV transplacentally infected animals 
would still be infectious for Culicoides sp. 
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The entomological trapping performed on the whole country by the Institute of 
Parasitology (University of Zurich, Switzerland) showed extremely low vector activity. In 
contrast to other studies in Belgium and France (Losson et al., 2007; Baldet et al., 2008; 
Zimmer et al., 2008) which demonstrated a significant vector activity throughout the year; 
in Switzerland only 20 Culicoides midges were trapped between early December 2007 and 
end of February 2008 (Francis Schaffner et al., personal communication). Therefore, it can 
be assumed that Culicoides sp. were not responsible for the TOV infection observed in this 
kid. 
In Switzerland, goats do not play an important economic role and are rarely moved 
for trade purposes. Therefore, they are infrequently tested for animal diseases and it is 
possible that TOV could have been circulating for a long time in the goat population. From 
the 2 infected holdings described in this study, it can be concluded that TOV does not easily 
infect cattle or alpacas. The TOV prevalence in goats on these holdings was high but none 
of the cattle kept on the same pasture or alpacas from the same holding had seroconverted to 
TOV. The low replication and transmission rate and restricted host range could also explain 
why this virus was not previously identified. Furthermore, it is possible that another 
ruminant species than goat or sheep may represent the reservoir host for TOV. Currently, 
extensive serological screening of goats throughout Switzerland is ongoing and during 
summer 2009, a survey in wild ruminant population will be performed.  
A similar situation, where the seroprevalence of BT in goats was quite high (33% to 
100%) without causing clinical disease in other ruminants, was described in Taiwan in 2003 
by Ting et al. (2005). A BTV-2 strain was detected in these clinically healthy goats. This 
demonstrates that BTV can circulate for a long period undetected in a population. On 
holding A, the number of rRT-PCR positive animals increased within 1 month, suggesting 
that the virus was still circulating during this period. 
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In contrast to classical BTV strains, TOV could not be propagated either in 
mammalian or in insect cell lines, or in ECE. This failure could be due to the too small 
amount of infectious virus in field or animal experiment samples. Another possible 
explanation is that TOV may require a different cellular receptor or use another entry 
mechanism than other BTV strains (Peter Mertens, personal communication). Primary cells, 
such as goat peripheric blood mononuclear cells, additional insect cell lines, like C6/36 
from Aedes sp., and isolation in newborn mice are currently evaluated. Once the adequate 
isolation method is determined, experiments with higher virus doses should be performed to 
confirm the apathogenic or low pathogenic phenotype for sheep, goats and cattle. More 
investigations should be done to determine the transmission routes of this virus and whether 
it is excreted. Furthermore, to discriminate between TOV and BTV in routine diagnostics, 
the development of TOV-specific SNT or ELISA and rRT-PCR are required. Viral RNA 
detection in buffy coat from experimentally infected animals, only during the early phase of 
viraemia suggests that in a first phase the virus is attached to or contained within the white 
blood cells, whereas later it is associated with the red blood cells, as it was demonstrated for 
other BTV strains (Whetter et al., 1989). 
The discovery of TOV raises several important questions about the evolution of this 
virus, its reservoir, epidemiology, virus-host interactions, and pathogenicity in various 
ruminant species. Therefore, the role of TOV as an animal pathogen needs to be urgently 
examined in detail, its role in BT epidemiology in Europe e.g. by creating new reassortants 
with other serotypes and its impact on eradication programs need to be evaluated.
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Figure legends 
 
Figure 1 
Detection of BTV RNA in EDTA blood (column) and body temperature (dotted line) of 
both experimentally infected goats and sheep. A, goat #1 (black) and #2 (white); B, sheep 
#4 (light gray), #6(dark gray) and #7 (black). Arrows indicate the time point of second 
inoculation. Ct-values were determined with rRT-PCR-CH. 
 
Figure 2 
Gross lesions of experimentally infected sheep. A, typical hemorrhage in the wall of the 
pulmonary artery as seen in bluetongue virus infection (sheep #3); B, multifocal 
endocardial hemorrhage in the right atrium (sheep #1); C, and petechial bleeding at the 
epicardial surface (sheep #7). 
  
Table 1: Inoculation scheme used for animal experiments 
animal first inoculation second inoculation 
goat #1 
40 mL mixed positive1 blood samples from 
holding B collected the 13.12.07, i.v. * (mean 
Ct-value 27.3, range from 22.2 to 31.8) 
7 days after first inoculation; 20 mL 
i.v. mixed positive1 blood samples 
from holding B collected the 15.01.08 
(Ct-value 31) goat #2 
40 mL mixed positive1 blood samples from 
holding B collected the 17.12.07, i.v. * (mean 
Ct-value 27.7, range from 23.1 to 31.7) 
sheep #1 
2 mL blood from goat #1 and goat #2 mixed: 
5x 0.1 mL i.d. + 1.5 mL s.c. (Ct-value 26.2) 
- 
sheep #2 
sheep #3 
16 days after first inoculation; 5 mL 
blood from goat #1 and 2 mixed, s.c. 
(Ct-value 26.1) 
sheep #4 
sheep #5 
2.1 mL blood from goat #1 and goat #2 
mixed, i.v. * (Ct-value 26.2) 
sheep #6 2 mL blood from goat 1 and goat 2 mixed: 
5x 0.1 mL i.d. + 1.5 mL s.c. (Ct-value 26.2) sheep #7 - 
sheep #8 
Negative control, inoculated with pre-
infection blood from goat #1 and #2 mixed; 
5x 0.1 mL i.d. + 1.5 mL s.c. 
- 
 
*i.v. injection in V. jugularis; i.d. intradermally; s.c. subcutaneously; Ct-values were determined with rRT-PCR-CH, after Trizol extraction.; 1 positive by rRT-PCR-CH 
  
Table 2: Laboratory results of all TOV-positive animals from holding A 
goat ID 
1st sample (29.11.07) 2nd sample (30.11.07) 3rd sample (24.01.08) 
VMR
D 
rRT-PCR-CH 
(Ct-value) 
rRT-PCR-
T* 
VMR
D 
ID.VET rRT-PCR-CH 
(Ct-value) 
VMRD ID.VET rRT-PCR-
CH 
1267399 + 36.8 42.7 + + 38.1 + - 33.1 
1267401 + 36.3 41.8 + + - + - 37.5 
1405498 ND ND ND + - 36.0 + - 33.0 
1267428 ND ND ND + - 31.4 + ND 26.7 
1267403 ND ND ND 
- + - - - 35.3 
1076041 ND ND ND 
- - - - + 32.4 
 
+, positive; -, negative; ND, not tested 
* rRT-PCR-Toussaint 
  
Table 3: Laboratory results of TOV-positive animals from holding B 
goat ID 
1st sample (14.12.07) 2nd sample (20.12.07) 3rd sample (15.01.08) 
VMRD 
rRT-PCR-CH 
(Ct-value) 
VMRD ID.Vet 
rRT-PCR-CH 
(Ct-value) 
VMR
D 
ID.Vet B.D.S.L. 
rRT-PCR-CH 
(Ct-value) 
1105114 
- 
28.1 
- - 
28.1 
- - - 
28.5 
1203553 
- 
25.2 + + 25.9 + + + 30.7 
1318718 
- 
31.8 
- - 
31.7 
- 
- + 33.8 
1318714 + 27.7 + - 28.7 + + + 30.6 
1318721 
- 
26.7 
- - 
27.9 
- 
- + 28.9 
1318722 
- 
27.7 
- - 
28.4 
- 
- + 28.3 
1318723 
- 
28.6 
- - 
29.6 + 
- + 30.3 
1122599 
- 
28.0 
- - 
28.6 
- 
- + 31.8 
1374200 
- 
22.2 
- - 
23.1 
- + + 27.0 
1126159 
- 
26.1 
- - 
26.6 + 
- + 28.6 
1497903 
- 
28.4 
- - 
27.4 + + + 27.6 
1374205 
- 
26.9 
- - 
26.6 
- 
- + 26.5 
 
+, positive; -, negative 
  
Table 4: Ct-values obtained with rRT-PCR-CH from TOV-positive organs of experimentally infected goats and sheep 
organs goat #1 goat #2 sheep #7 
spleen 24.4 23.8 23.8 
lungs 27.6 26.7 
- 
prescapular lymph nodes 31.2 31.8 
- 
popliteal and inguinal lymph nodes 31.5 31.2 
- 
palatine tonsil 30.1 31.2 
- 
kidney ND ND 34.1 
 
-, negative; ND, not tested 
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